Intestinal Enterococcus faecium colonization improves host defense during polymicrobial peritonitis

Journal of Infectious Diseases

Volumn 200, Issue 5, 2009, Pages 735-744

  Leendertse, Masja ^a,b   Willems, Rob J L ^b   Oei, G Anneke ^a   Florquin, Sandrine ^a   Bonten, Marc J M ^b   Van Der Poll, Tom ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; AMYLOID A PROTEIN; ASPARTATE AMINOTRANSFERASE; CILASTATIN PLUS IMIPENEM; CREATININE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; INTERLEUKIN 10; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL OVERGROWTH; BACTERIAL PERITONITIS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CELL COUNT; COLONY FORMING UNIT; CONTROLLED STUDY; CONVALESCENCE; CREATININE BLOOD LEVEL; ENTEROCOCCUS FAECIUM; FEMALE; HOST RESISTANCE; IMMUNE RESPONSE; INFLAMMATION; INTESTINE FLORA; KIDNEY INJURY; LEUKOCYTE DIFFERENTIAL COUNT; LIVER INJURY; MOUSE; NONHUMAN; PERITONEAL FLUID LEVEL; POLYMICROBIAL PERITONITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPSIS; TISSUE LEVEL; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANIMAL; ANTIBIOTIC RESISTANCE; ASCITES FLUID; BACTERIAL INFECTION; BACTERIUM; BLOOD; DRUG EFFECT; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; HETEROZYGOTE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; LUNG; MICROBIOLOGY; PATHOLOGY; PERITONITIS;

ANIMALS; ASCITIC FLUID; BACTERIA; BACTERIAL INFECTIONS; BLOOD; CARRIER STATE; COLONY COUNT, MICROBIAL; CYTOKINES; ENTEROCOCCUS FAECIUM; FEMALE; GASTROINTESTINAL TRACT; HUMANS; LIVER; LUNG; MICE; PERITONITIS; VANCOMYCIN RESISTANCE;

EID: 69849088189     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/603542     Document Type: Article

References (40)

1. 1. Weinstein JW, Roe M, Towns M, et al. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. Infect Control Hosp Epidemiol 1996; 17:36-41. (Pubitemid 126482560)
2. 2. Bonten MJ, Hayden MK, Nathan C, et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 1996; 348:1615-1619 (Pubitemid 27007060)
3. Bonten MJ, Slaughter S, Ambergen AW, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998; 158:1127-1132
4. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29:996-1011.
5. Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003;51(Suppl 3):iii13-21.
6. Willems RJ, Top J, van Santen M, et al. Global spread of vancomycinresistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005; 11:821-828
7. 7. Montravers P, Gauzit R, Muller C, Marmuse JP, Fichelle A, Desmonts JM. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996; 23:486-494 (Pubitemid 26304496)
8. Nichols RL, Muzik AC. Enterococcal infections in surgical patients: the mystery continues. Clin Infect Dis 1992; 15:72-76
9. 9. Sitges-Serra A, Lopez MJ, Girvent M, Almirall S, Sancho JJ. Postoperative enterococcal infection after treatment of complicated intraabdominal sepsis. Br J Surg 2002; 89:361-367 (Pubitemid 34227039)
10. 10. Sotto A, Lefrant JY, Fabbro-Peray P, et al. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother 2002; 50:569-576 (Pubitemid 35214798)
11. 11. Matlow AG, Bohnen JM, Nohr C, Christou N, Meakins J. Pathogenicity of enterococci in a rat model of fecal peritonitis. J Infect Dis 1989; 160:142-145 (Pubitemid 19163004)
12. Montravers P, Andremont A, Massias L, Carbon C. Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. J Infect Dis 1994; 169:821-830
13. Montravers P, Mohler J, Saint Julien L, Carbon C. Evidence of the proinflammatory role of Enterococcus faecalis in polymicrobial peritonitis in rats. Infect Immun 1997; 65:144-149
14. Treitman AN, Yarnold PR, Warren J, Noskin GA. Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J Clin Microbiol 2005; 43:462-463
15. Top J, Willems R, Blok H, et al. Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin Microbiol Infect 2007; 13:316-319
16. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock-a review of laboratory models and a proposal. J Surg Res 1980; 29: 189-201.
17. Hendrickx AP, van Wamel WJ, Posthuma G, Bonten MJ, Willems RJ. Five genes encoding surface-exposed LPXTG proteins are enriched in hospital-adapted Enterococcus faecium clonal complex 17 isolates. J Bacteriol 2007; 189:8321-8332
18. Whitman MS, Pitsakis PG, DeJesus E, Osborne AJ, Levison ME, Johnson CC. Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model. Antimicrob Agents Chemother 1996; 40:1526-1530
19. Leendertse M, Willems RJ, Giebelen IA, et al. Cecal ligation and puncture induced sepsis impairs host defense against Enterococcus faecium peritonitis. Intensive Care Med 2009; 35:924-932
20. 20. Newcomb D, Bolgos G, Green L, Remick DG. Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity. Shock 1998; 10:110-117 (Pubitemid 128463842)
21. Top J, Schouls LM, Bonten MJ, Willems RJ. Multiple-locus variablenumber tandem repeat analysis, a novel typing scheme to study the genetic relatedness and epidemiology of Enterococcus faecium isolates. J Clin Microbiol 2004;42:4503-4511
22. Leendertse M, Willems RJ, Giebelen IA, van den Pangaart PS, Bonten MJ, van der Poll T. The acute-phase response impairs host defence against Enterococcus faecium peritonitis. Immunology 2008 [Epub ahead of print].
23. Wells CL, Hess DJ, Erlandsen SL. Impact of the indigenous flora in animal models of shock and sepsis. Shock 2004; 22:562-568
24. Willems RJ, Bonten MJ. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity. Curr Opin Infect Dis 2007;20: 384-390
25. Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore) 1988; 67: 248-269
26. 26. Caballero-Granado FJ, Becerril B, Cisneros JM, Cuberos L, Moreno I, Pachón J. Case-control study of risk factors for the development of enterococcal bacteremia. Eur J Clin Microbiol Infect Dis 2001; 20: 83-90. (Pubitemid 32247102)
27. Burnett RJ, Haverstock DC, Dellinger EP, et al. Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial. Surgery 1995; 118:716-21; discussion 721-723
28. Hopkins JA, Lee JC, Wilson SE. Susceptibility of intra-abdominal isolates at operation: a predictor of postoperative infection. Am Surg 1993; 59:791-796
29. 29. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002; 136:834-844 (Pubitemid 34568654)
30. Barie PS, Vogel SB, Dellinger EP, et al. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenemcilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group. Arch Surg 1997; 132:1294-1302
31. Onderdonk AB, Bartlett JG, Louie T, Sullivan-Seigler N, Gorbach SL. Microbial synergy in experimental intra-abdominal abscess. Infect Immun 1976; 13:22-26
32. Weinstein WM, Onderdonk AB, Bartlett JG, Gorbach SL. Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun 1974; 10:1250-1255
33. Leendertse M, Willems RJ, Giebelen IA, et al. TLR2-dependent MyD88 signaling contributes to early host defense in murine Enterococcus faecium peritonitis. J Immunol 2008; 180:4865-4874
34. Leendertse M, Willems RJ, Giebelen IA, Roelofs JJ, Bonten MJ, van der Poll T. Neutrophils are essential for rapid clearance of Enterococcus faecium in mice. Infect Immun 2009; 77:485-491
35. Dupont H, Montravers P, Mohler J, Carbon C. Disparate findings on the role of virulence factors of Enterococcus faecalis in mouse and rat models of peritonitis. Infect Immun 1998; 66:2570-2575
36. Isolauri E, Sutás Y, Kankaanpaa P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr 2001;73:444S-50S.
37. Benyacoub J, Czamecki-Maulden GL, Cavadini C, et al. Supplementation of food with Enterococcus faecium (SF68) stimulates immune functions in young dogs. J Nutr 2003; 133:1158-1162
38. Boirivant M, Strober W The mechanism of action of probiotics. Curr Opin Gastroenterol 2007; 23:679-692
39. Sabia C, de Niederhausem S, Guerrieri E, et al. Detection of bacteriocin production and virulence traits in vancomycin-resistant enterococci of different sources. J Appl Microbiol 2008; 104:970-979
40. Svetoch EA, Eruslanov BV, Perelygin VV, et al. Diverse antimicrobial killing by Enterococcus faecium E 50-52 bacteriocin. J Agrie Food Chem 2008;56:1942-1948